103 related articles for article (PubMed ID: 33902381)
1. Cytoplasmic phosphorylated ERK1/2 expression in patients with melanoma is associated with tumor stage and metastasis.
Tseng YS; Wu PR; Lu JW; Wang YF; Yeh KT; Lin SH
Biotech Histochem; 2022 Feb; 97(2):118-125. PubMed ID: 33902381
[TBL] [Abstract][Full Text] [Related]
2. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
[TBL] [Abstract][Full Text] [Related]
3. High nuclear phosphorylated extracellular signal-regulated kinase expression associated with poor differentiation, larger tumor size, and an advanced stage of breast cancer.
Kuo HT; Hsu HT; Chang CC; Jiang MC; Yeh CM; Shen KH; Hsu PC; Tai CJ
Pol J Pathol; 2013 Oct; 64(3):163-9. PubMed ID: 24166600
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
[TBL] [Abstract][Full Text] [Related]
5. Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Palmer AA; Zhang XD; Thompson JF; Bron LP; Hersey P
J Clin Pathol; 2005 Nov; 58(11):1163-9. PubMed ID: 16254105
[TBL] [Abstract][Full Text] [Related]
6. Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome.
Jørgensen K; Holm R; Maelandsmo GM; Flørenes VA
Clin Cancer Res; 2003 Nov; 9(14):5325-31. PubMed ID: 14614017
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
[TBL] [Abstract][Full Text] [Related]
8. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.
Mirmohammadsadegh A; Mota R; Gustrau A; Hassan M; Nambiar S; Marini A; Bojar H; Tannapfel A; Hengge UR
J Invest Dermatol; 2007 Sep; 127(9):2207-15. PubMed ID: 17508026
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
10. TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.
Weiss MB; Abel EV; Mayberry MM; Basile KJ; Berger AC; Aplin AE
Cancer Res; 2012 Dec; 72(24):6382-92. PubMed ID: 23222305
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
PLoS One; 2011 Feb; 6(2):e17578. PubMed ID: 21386910
[TBL] [Abstract][Full Text] [Related]
12. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
14. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
[TBL] [Abstract][Full Text] [Related]
15. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
16. CSE1L Links cAMP/PKA and Ras/ERK pathways and regulates the expressions and phosphorylations of ERK1/2, CREB, and MITF in melanoma cells.
Lee WR; Shen SC; Wu PR; Chou CL; Shih YH; Yeh CM; Yeh KT; Jiang MC
Mol Carcinog; 2016 Nov; 55(11):1542-1552. PubMed ID: 26331446
[TBL] [Abstract][Full Text] [Related]
17. Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity.
Hutchinson PE; Halsall JA; Popovici S; Papadogeorgakis E; Osborne JE; Powley IR; Dasari D; Saldanha G; Pringle JH
Melanoma Res; 2018 Oct; 28(5):410-422. PubMed ID: 30004989
[TBL] [Abstract][Full Text] [Related]
18. Expression of activated Akt in benign nevi, Spitz nevi and melanomas.
Kantrow SM; Boyd AS; Ellis DL; Nanney LB; Richmond A; Shyr Y; Robbins JB
J Cutan Pathol; 2007 Aug; 34(8):593-6. PubMed ID: 17640227
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
Prieto VG; Mourad-Zeidan AA; Melnikova V; Johnson MM; Lopez A; Diwan AH; Lazar AJ; Shen SS; Zhang PS; Reed JA; Gershenwald JE; Raz A; Bar-Eli M
Clin Cancer Res; 2006 Nov; 12(22):6709-15. PubMed ID: 17121890
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers.
Nakamura M; Han B; Nishishita T; Bai Y; Kakudo K
J Mol Endocrinol; 2007 Dec; 39(6):375-84. PubMed ID: 18055485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
